Lead and cadmium have stay of execution in EU
This article was originally published in Clinica
Executive Summary
The European Commission has decided to allow lead and cadmium, frequently used in medical devices, including clinical analysers, to remain on the market for longer than originally anticipated in the context of its Directive on the restriction of the use of certain hazardous substances in electrical and electronic equipment (the RoHS Directive, 2002/95/EC).